Changes in cytokines and neurotrophins in Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 60, 2000, Pages 277-290

  Nagatsu, T ^a   Mogi, M ^a   Ichinose, H ^a   Togari, A ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLSALICYLIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; ISOQUINOLINE; NERVE GROWTH FACTOR; NEUROTOXIN; NEUROTROPHIN; OXIDOPAMINE; PROTEIN BCL 2; PROTEIN P55; TACROLIMUS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GLIA CELL; HUMAN; MOUSE; NERVE CELL DEGENERATION; NERVE ENDING; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0034525420     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6301-6_19     Document Type: Conference Paper

References (59)

1. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
2. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging
3. Aspirin and salycylate protect against MPTP-induced dopamine depletion in mice
4. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
5. Interleukin 1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
6. Immunocytochemical analysis of tumor necrosis factor and its receptor in Parkinson's disease
7. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
8. Programmed cell death: Does it play a role in Parkinson's disease?
9. Possible relation of atypical parkinsonism in the French west indies with consumption of tropical plants and case-control study
10. Microglia and cytokines in neurological diseases, with special reference to AIDS and Alzheimer's disease
11. Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro
12. Pathogenesis and preclinical course of Parkinson's disease
13. Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson's disease
14. CSF biopterin levels and clinical features of patients with juvenile parkinsonism
15. Functional recovery in parkinsonian monkeys treated with GDNF
16. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene
17. Molecular genetics of dopa-responsive dystonia
18. Molecular cloning of the human Nurr 1 gene: Characterization of the human gene and cDNAs
19. Is there apoposis in Lewy body disease?
20. Mutation in the perkin gene cause autosomal recessive juvenile parkinsonism
21. On the question of apoptosis in the parkinsonian substantia nigra
22. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: A novel endogenous amine in mouse brain and parkinsonian brain
23. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease
24. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer's disease
25. β-Carbolinium cations, endogenous MPP+ analogs in the lumber cerebrospinal fluid of parkinsonian patients
26. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains
27. Histochemical detection of apoptosis in Parkinson's disease
28. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
29. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
30. Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease
31. Brain β2-microglobulin are elevated in the striatum in Parkinson's disease
32. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
33. bcl-2 protein is increased in the brain from parkinsonian patients
34. Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain
35. The soluble form of Fas molecule is elevated in parkinsonian brain tissues
36. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum
37. Increase in level of tumor necrosis factor (TNF)-α in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-α induction
38. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
39. Caspase activities and tumor necrosis factor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
40. Genes for human catecholamine-synthesizing enzymes
41. Biochemical aspects of Parkinson's disease
42. Isoquinoline neurotoxins and Parkinson's disease
43. Cytokines in Parkinson's disease
44. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: Biochemcal, pathological and behavioral studies
45. Oxidation of N-methyl(R)salsolinol: Involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines
46. Fetal nigral transplantation as a therapy for Parkinson's disease
47. Mutation of the ́-synuclein gene identified in families with Parkinson's disease
48. Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats
49. Hereditary progressive dystonia with marked diurnal fluctuation
50. Immunophilins in the nervous system
51. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methylpyridinium ion activity: Involvement of the glutathione system
52. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
53. Parkinson's disease: The apoptosis hypothesis
54. Risk of Alzheimer's disease and duration of NSAID use
55. Biochemical and fluorodopa positron emmision tomograph findings in an asymptomatic carrier of the gene for dopa-responsive dystonia
56. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease
57. TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid
58. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
59. BDNF enhances the functional reinnervation of the striatum by grafted fetal DA neurons